Official Publications Novartis AG

Equities

Market Closed - Swiss Exchange Other stock markets 11:30:12 2024-05-24 am EDT			5-day change	1st Jan Change
91.74 ^CHF	-1.11%		-1.75%	+8.09%

May. 25	Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio	DJ
May. 25	Novartis Presents Results from a Pre-Specified Interim Analysis of the Phase III Align Study	CI

Slide show Q1	Apr. 22	CO
1st quarter results	Apr. 22	CO
1st quarter results	Apr. 22	CO
1st quarter results	Apr. 22	CO
1st quarter report	Apr. 22	CO
Shareholders meeting voting results	Mar. 04	CO
Minutes of the general assembly	Mar. 04	CO
Minutes of the general assembly	Mar. 04	CO
Minutes of the general assembly	Mar. 04	CO
Changes in management and corporate officers	Feb. 15	CO
Slide show results	Jan. 30	CO
Annual results	Jan. 30	CO
Annual results	Jan. 30	CO
Annual results	Jan. 30	CO
SEC Filing 20 F	Jan. 30	CO
Integrated report	Jan. 30	CO
Financial report	Jan. 30	CO
Annual Report	Jan. 30	CO
Slide show Q3	23-10-23	CO
3rd quarter results	23-10-23	CO
3rd quarter results	23-10-23	CO
3rd quarter results	23-10-23	CO
3rd quarter report	23-10-23	CO
Slide show half-year results	23-07-17	CO
1st-half-year results	23-07-17	CO